BSE Live
Apr 17, 16:01Prev. Close
350.55
Open Price
354.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 17, 15:59Prev. Close
350.75
Open Price
351.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
358.10 (456)
| Profit & Loss account of Biocon (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 1,833.30 | 1,723.60 | 1,731.50 | 1,497.40 | 1,822.80 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 1,833.30 | 1,723.60 | 1,731.50 | 1,497.40 | 1,822.80 | |
| Total Operating Revenues | 2,242.60 | 2,127.30 | 1,992.90 | 1,738.20 | 2,028.40 | |
| Other Income | 242.30 | 193.00 | 271.40 | 187.20 | 150.20 | |
| Total Revenue | 2,484.90 | 2,320.30 | 2,264.30 | 1,925.40 | 2,178.60 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 1,085.40 | 1,033.30 | 978.90 | 912.30 | 760.70 | |
| Purchase Of Stock-In Trade | 0.00 | 0.50 | 2.10 | 1.70 | 0.90 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -54.60 | -99.10 | 3.20 | -105.80 | 36.70 | |
| Employee Benefit Expenses | 501.30 | 452.30 | 433.80 | 367.70 | 390.20 | |
| Finance Costs | 236.90 | 198.80 | 69.60 | 0.40 | 0.40 | |
| Depreciation And Amortisation Expenses | 127.80 | 121.10 | 116.90 | 108.20 | 103.50 | |
| Other Expenses | 547.80 | 487.60 | 554.10 | 501.20 | 527.40 | |
| Total Expenses | 2,431.50 | 2,184.50 | 2,155.90 | 1,785.70 | 1,819.80 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 53.40 | 135.80 | 108.40 | 139.70 | 358.80 | |
| Exceptional Items | 607.50 | 14.50 | 2,862.80 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 660.90 | 150.30 | 2,971.20 | 139.70 | 358.80 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 30.60 | 15.10 | 25.60 | 32.20 | 46.20 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | -107.10 | -28.50 | -27.30 | |
| Deferred Tax | 21.00 | 15.90 | -9.90 | -7.10 | 4.80 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 51.60 | 31.00 | 122.80 | 53.60 | 78.30 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 609.30 | 119.30 | 2,848.40 | 86.10 | 280.50 | |
| Profit/Loss From Continuing Operations | 609.30 | 119.30 | 2,848.40 | 86.10 | 280.50 | |
| Profit/Loss For The Period | 609.30 | 119.30 | 2,848.40 | 86.10 | 280.50 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 5.09 | 1.00 | 23.87 | 0.72 | 2.36 | |
| Diluted EPS (Rs.) | 5.09 | 1.00 | 23.82 | 0.72 | 2.34 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 60.00 | 180.10 | 60.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 10.00 | 10.00 | 30.00 | 10.00 | 0.00 |
17.04.2026
Kiran Mazumdar-Shaw flags Bengaluru’s NH-44 issues in meeting with Nitin Gadkari
08.04.2026
31.03.2026
11.03.2026
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth